AGPS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.477800E-01
Normal-vs-Stage2
7.188000E-01
Normal-vs-Stage3
3.602600E-01
Normal-vs-Stage4
3.148800E-01
Stage1-vs-Stage2
1.187600E-01
Stage1-vs-Stage3
7.646000E-01
Stage1-vs-Stage4
4.287600E-02
Stage2-vs-Stage3
1.254590E-01
Stage2-vs-Stage4
2.134600E-01
Stage3-vs-Stage4
5.062100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.445800E-01
Normal-vs-AfricanAmerican
6.841600E-01
Normal-vs-Asian
8.051600E-01
Caucasian-vs-AfricanAmerican
6.364000E-01
Caucasian-vs-Asian
3.678400E-01
AfricanAmerican-vs-Asian
3.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.943400E-01
Normal-vs-Female
8.895200E-01
Male-vs-Female
6.074200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.112600E-01
Normal-vs-Age(41-60Yrs)
5.388800E-01
Normal-vs-Age(61-80Yrs)
9.777000E-01
Normal-vs-Age(81-100Yrs)
9.063800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.215400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.544800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.256800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.974000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.708830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.063200E-01
Normal-vs-Daily Drinker
8.459000E-01
Normal-vs-Weekly Drinker
8.788600E-01
Normal-vs-Occasional Drinker
5.889000E-01
Normal-vs-Social Drinker
8.701200E-01
Non Drinker-vs-Daily Drinker
8.219400E-01
Non Drinker-vs-Weekly Drinker
9.703600E-01
Non Drinker-vs-Occasional Drinker
1.747410E-01
Non Drinker-vs-Social Drinker
5.757800E-01
Daily Drinker-vs-Weekly Drinker
8.747000E-01
Daily Drinker-vs-Occasional Drinker
1.776000E-01
Daily Drinker-vs-Social Drinker
5.134000E-01
Weekly Drinker-vs-Occasional Drinker
2.103600E-01
Weekly Drinker-vs-Social Drinker
5.933800E-01
Occasional Drinker-vs-Social Drinker
5.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.577400E-01
Normal-vs-Grade 2
2.423700E-02
Normal-vs-Grade 3
3.532300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.421000E-03
Grade 1-vs-Grade 3
2.240700E-03
Grade 1-vs-Grade 4
2.577400E-01
Grade 2-vs-Grade 3
3.443800E-01
Grade 2-vs-Grade 4
2.423700E-02
Grade 3-vs-Grade 4
3.532300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.783800E-01
Normal-vs-NonDiabetic
9.463200E-01
Diabetic-vs-NonDiabetic
8.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.427000E-01
Normal-vs-NoPancreatitis
9.023200E-01
Pancreatitis-vs-NoPancreatitis
4.302600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.028400E-01
Normal-vs-N1
6.794200E-01
N0-vs-N1
6.417800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.566600E-01
Normal-vs-TP53-NonMutant
8.853200E-01
TP53-Mutant-vs-TP53-NonMutant
5.961200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
